Home Newsfeeds DICE Therapeutics Q3 EPS $(0.55) Up From $(2.15) YoY

DICE Therapeutics Q3 EPS $(0.55) Up From $(2.15) YoY

DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.55) per share. This is a 74.42 percent increase over losses of $(2.15) per share from the same period last year.

byBill Haddad

November 9, 2022

1 minute read

DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.55) per share. This is a 74.42 percent increase over losses of $(2.15) per share from the same period last year.

Morgan Stanley Reinstates Equal-Weight on Parker Hannifin, Announces $311 Price Target

By Benzinga Newsdesk

January 6, 11:10 AM

Morgan Stanley analyst Joshua Pokrzywinski reinstates Parker Hannifin (NYSE:PH) with a Equal-Weight and announces $311 price target.

What’s Going On With United Airlines Shares

By Henry Khederian

October 18, 2:23 PM

United Airlines Holdings Inc (NASDAQ: UAL) shares are trading higher by 2.45% to $36.98 during Tuesday's trading session in anticipation of the company's third-quarter earnings report, confirmed for today's after-hours session.

DAL